Cosmo Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Giovanni Di Napoli
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.9yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/S Still Appears To Be Reasonable
Nov 22
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues
May 02Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 28Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher
Mar 26Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear
Dec 01Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 29We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt
Nov 24Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals
Mar 31These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well
Aug 02Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)
May 20Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly
Apr 03When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?
Mar 07CEO
Giovanni Di Napoli (50 yo)
less than a year
Tenure
Mr. Giovanni Di Napoli is Chief Executive Officer and Director of Cosmo Pharmaceuticals N.V. from May 24, 2024. He was President of Gastrointestinal at Medtronic plc. He is an accomplished leader with an e...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 18.9yrs | €1.16m | no data | |
| Executive VP of Corporate Governance | less than a year | no data | no data | |
| Chief Executive Officer & Director | less than a year | no data | no data | |
| Founder & Non-Executive Director | 18.9yrs | €400.00k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | 3.9yrs | no data | no data | |
| Qualified Person & Technical Director | 13.3yrs | no data | no data | |
| Chief Scientific Officer | 2.7yrs | no data | no data | |
| Head of Investor Relations | 2.9yrs | no data | no data | |
| Chief People Officer | 3.9yrs | no data | no data | |
| Chief Manufacturing Officer | 27.9yrs | no data | no data | |
| President of Cosmo Intelligent Medical Devices | no data | no data | no data |
2.9yrs
Average Tenure
52yo
Average Age
Experienced Management: COPN's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 18.9yrs | €1.16m | no data | |
| Executive VP of Corporate Governance | less than a year | no data | no data | |
| Chief Executive Officer & Director | less than a year | no data | no data | |
| Founder & Non-Executive Director | 18.9yrs | €400.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | 12.7yrs | €128.79k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Director | less than a year | no data | no data |
0.6yrs
Average Tenure
61yo
Average Age
Experienced Board: COPN's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.